The translation of mRNA encoding melanoma antigen was found in DCs resident at lymphoid organs, inducing strong polyclonal functional CD4+ and CD8+ T cells against antigens in patients with advanced melanoma.[168] BNT111 monotherapy, or combination therapy with anti‐PD‐1 mAbs demonstrated tumor regression in patients. The gene discussed is CD8A; the disease is melanoma.